Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Understanding Plasmodium falciparum malaria in the Amazon
RBR-634ymd5Not yet recruiting
- Sponsor
- Evandro Chagas National Institute of Infectology
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of artesunate + mefloquine in Malaria and malaria (2 arms), sponsored by Evandro Chagas National Institute of Infectology. Primary endpoints: In vivo parasite clearance kinetics, In vitro parasite clearance kinetics and 2 more. Planned start Oct 2021; status: not yet recruiting.
02
Drugs
artesunate + mefloquine
03
Conditions
Malariamalaria
Beyond the preview
Go deeper on RBR-634ymd5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-634ymd5.